Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 581.20
+14.00 (2.47%)
At close: Dec 5, 2025
Coloplast Market Cap
Coloplast has a market cap or net worth of 130.98 billion as of December 5, 2025. Its market cap has decreased by -34.86% in one year.
Market Cap
130.98B
Enterprise Value
152.68B
Revenue
27.87B
Ranking
n/a
PE Ratio
36.03
Stock Price
581.20
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 130.98B, an increase of 2,127.61%. That is a compound annual growth rate of 11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 130.98B | -26.00% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | 197.71B | 12.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.38T |
| Genmab | 125.17B |
| ALK-Abelló | 50.74B |
| Demant | 46.10B |
| H. Lundbeck | 42.14B |
| Zealand Pharma | 35.71B |
| Ambu A/S | 23.26B |
| Embla Medical | 15.90B |